RegenLab develop patented devices and protocols for the biostimulation of our own stem cells.

RegenLab cell therapies, as part of the regenerative medicine, are focused in isolation and application of patient’s own cells from blood, fat (adipocyte), bone marrow (stem cells) etc.

The treatments are autologous and point of care, therefore inherently efficient.

Regenlab is an independent Swiss biotech company based in Le Mont-sur-Lausanne, Switzerland and operating in the national and international healthcare market.